In compliance with current regulations, let us know which audience you belong to:
Light Modulation®
The power of light, cubed.
LM® Low-level Light Therapy is a unique, light-based photobiomodulation technology. We developed and patented for medical use the technology originally employed by NASA (i.e., Low-level Laser Therapy) to treat wounds of astronauts in space.
LM® LLLT has nothing to do with Red Light Therapy (RLT), which only acts on the surface of the dermis—instead, LM® LLLT works at biological level, generating endogenous heat through powerful LEDs stimulating ATP production in cells.
Photobiomodulation therapy with LM® LLLT is a unique and completely painless form of near-infrared light therapy (NILT), highly effective for treating a broad spectrum of conditions. Our patented photobiomodulation technology leverages various wavelengths—red, blue, yellow, and infrared*—to cater to diverse medical needs.
In ophthalmology, it addresses both anterior (DED, Chalazion) and posterior (dAMD) segment conditions. Additionally, LM® LLLT extends its benefits to dermatology and trichology, ensuring versatile and effective outcomes by stimulating ATP production.
The degree of simplicity offered by LM® LLLT technology to the operator, and the convenience hence provided to the patient benefitting from its therapy is, put simply, unmatched. This, paired with LM® LLLT exceptional efficacy in addressing a broad spectrum of anterior and posterior segment conditions, along with dermatologic and trichologic concerns, makes it a true game-changer.
LM® LLLT has recently been studied in a piece of research that compared it directly against IPL. The study has confirmed the efficacy of LM® LLLT, proving also its superior performance against traditional IPL technologies.
Another recent scientific paper has confirmed that LM® LLLT, employed jointly with OPE® IPL, is the key factor in effectively managing the most severe cases of recalcitrant MGD-induced DED and other ocular surface diseases.
LM® LLLT’s potential extends beyond direct treatment of most ocular surface diseases, playing a crucial role in both cataract and refractive surgeries. Literature shows that LM® LLLT enhances outcomes in cataract and refractive surgeries by stabilizing tear film and reducing ocular discomfort when used pre- and post-surgery. Whether we’re talking of traditional cataracts, premium IOLs or refractive, we’re certain LM® LLLT can play a significant role in elevating any surgery. That’s why the Espansione Ecosystem, above all through LM® LLLT, is the best option to elevate your surgery routine.
Operators and patients can enjoy the unique benefits of LM® LLLT technology.